Pembrolizumab, an immune checkpoint inhibitor, was approved by the US Food and Drug Administration (FDA) for the treatment of patients with resectable locally advanced head and neck record carcinoma, whose tumors express PD-L1 [Combined Positive Score (CPS) ≥1] as determined by a test approved by the FDA. The FDA approval relies on data from the […]
Tag Archives: approval
01
Feb
Feb
The US Food and Drug Administration (FDA) has approved Suzetrigine, a brand new non-opioid pain reliever relief medication, which was sold under the brand name Journavx to treat medium-weight to severe acute pain in adults. Journavx from Vertex Pharmaceuticals marks the primary recent class of pain relievers, which has been receiving the FDA approval for […]
17
Sep
Sep
The U.S. Food and Drug Administration has approved Eli Lilly’s eczema drug. It offers a brand new treatment option for individuals with moderate to severe atopic dermatitis for whom topical medications are ineffective. Atopic dermatitis is a typical type of eczema which causes dry, itchy and flaky patches of skin. It’s probably the most common […]
24
Aug
Aug
With case numbers rising this summer, the U.S. Food and Drug Administration (FDA) has approved using two updated COVID-19 mRNA vaccines that concentrate on the currently circulating strains of the virus. The updated COVID vaccines from Pfizer-BioNTech and Moderna goal the present KP.2 strain of SARS-CoV-2, a derivative of the highly contagious omicron subvariant JN.1. […]